General form of registration statement for all companies including face-amount certificate companies

Inventories, net - Shelf-life (Details)

v3.23.2
Inventories, net - Shelf-life (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 30, 2022
USD ($)
Aug. 31, 2022
USD ($)
Feb. 28, 2022
USD ($)
Feb. 28, 2023
USD ($)
Feb. 28, 2022
USD ($)
May 31, 2022
USD ($)
May 31, 2021
USD ($)
Inventory Realizable Value              
2023           $ 6,903  
2024           20,201  
2025           31,241  
2026           33,075  
Inventories, gross           91,420  
Inventory charge           (73,491)  
Raw materials, net of reserves           10,200  
Inventory charged-off   $ 2,700 $ 5,559 [1] $ 20,633 $ 8,916 [1] $ 73,490 $ 5,027
Number of batches not saleable           5  
Total number of batches manufactured           9  
Raw materials           $ 16,264 28,085
Inventory, Noncurrent           17,929 93,479
Additional Inventory           (2,060) $ 79,359
Other Assets | Samsung BioLogics Co., Ltd. ("Samsung")              
Inventory Realizable Value              
Specialized raw materials     $ 2,700   $ 2,700    
Raw Materials              
Inventory Realizable Value              
2023           5,079  
2024           18,536  
2025           2,099  
2026           731  
Inventories, gross           26,445  
Inventory charge           (10,181)  
Inventory, Noncurrent           16,264  
Specialized              
Inventory Realizable Value              
2023           3,658  
2024           682  
2025           2,099  
2026           731  
Inventories, gross           7,170  
Inventory charge           (7,170)  
Resins              
Inventory Realizable Value              
2024           16,264  
Inventories, gross           16,264  
Inventory charged-off $ 16,300            
Inventory, Noncurrent           16,264  
Other              
Inventory Realizable Value              
2023           1,421  
2024           1,590  
Inventories, gross           3,011  
Inventory charge           (3,011)  
Inventory charged-off           $ 63,300  
Number of batches not saleable           4  
Five Batches Of Drug Product              
Inventory Realizable Value              
Raw materials           $ 29,100  
Four Batches Of Drug Product              
Inventory Realizable Value              
Raw materials           34,200  
Bulk Drug Substance              
Inventory Realizable Value              
2023           1,824  
2024           1,665  
Inventories, gross           3,489  
Inventory charge           $ (1,824)  
Inventory charged-off $ 1,700            
Shelf life           4 years  
Extended shelf life           4 years  
Inventory, Noncurrent           $ 1,665  
Drug Products              
Inventory Realizable Value              
2025           29,142  
2026           32,344  
Inventories, gross           61,486  
Inventory charge           $ (61,486)  
[1] See Note 2, Summary of Significant Accounting PoliciesRevision and Restatement of Financial Statements.